Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| XENON PHARMACEUTICALS | 22 | - | +48,61 % | ||
| DYNE THERAPEUTICS | 11 | - | +19,03 % | ||
| REGENERON PHARMACEUTICALS | 8 | 22 | +2,08 % | ||
| ARS PHARMACEUTICALS | 7 | - | -0,22 % | ||
| UNITED THERAPEUTICS | 6 | 8 | +9,25 % | ||
| ZEVRA THERAPEUTICS | 6 | 1 | +1,94 % | ||
| UNIQURE | 6 | - | +24,68 % | ||
| SEPTERNA | 5 | 16 | +0,49 % | ||
| BIONTECH | 5 | 13 | +1,14 % | ||
| ORIC PHARMACEUTICALS | 5 | 2 | -18,49 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:30 | Jefferies reiterates Sarepta stock Buy rating on DMD data | 1 | Investing.com | ||
| 21:30 | Prothena earns $50M milestone from Novo Nordisk for drug trial | 1 | Investing.com | ||
| 21:30 | Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M | 3 | Seeking Alpha | ||
| 21:30 | Xenon Pharmaceuticals launches $500 million stock offering | 1 | Investing.com | ||
| 21:30 | Earnings Breakdown: Septerna Q4 | 1 | Benzinga.com | ||
| 21:28 | ZEVRA THERAPEUTICS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 21:23 | ZEVRA THERAPEUTICS, INC. - 10-K, Annual Report | 3 | SEC Filings | ||
| 21:22 | Jefferies bekräftigt Kaufempfehlung für Sarepta nach neuen DMD-Studiendaten | 1 | Investing.com Deutsch | ||
| 21:18 | Coherus Oncology, Inc.: Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update | 1 | GlobeNewswire (USA) | ||
| 21:18 | Insights into Coherus Oncology Q4 Earnings | 1 | Benzinga.com | ||
| 21:18 | Zevra Therapeutics Q4 Earnings Report: What Investors Need to Know | 1 | Benzinga.com | ||
| 21:18 | BioNTech Q4 2025 Earnings Preview | 6 | Seeking Alpha | ||
| 21:18 | Earnings Summary: Septerna Q4 | 5 | Benzinga.com | ||
| 21:17 | Design Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 21:12 | Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 | 1 | GlobeNewswire (USA) | ||
| 21:12 | Zevra Therapeutics: Zevra Reports Fourth Quarter and Full Year 2025 Financial Results | 6 | GlobeNewswire (USA) | ||
| 21:12 | Septerna, Inc.: Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results | 2 | GlobeNewswire (USA) | ||
| 21:12 | Septerna, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 21:09 | Larimar Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21:09 | Design Therapeutics, Inc. - 10-K, Annual Report | 5 | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.